Norgine has today announced the launch of MOVICOL® Ready to Take in Australia.

MOVICOL® Ready to Take is used for the treatment of acute and chronic constipation in adolescents, adults and the elderly.

Belinda Nankivell, Terry White Chemists, Chatswood Chase and QCPP State Manager, NSW Guild, commented that many patients have told us that they are embarrassed by their condition and they are looking for a product that is convenient, quick to administer, portable and discreet. “MOVICOL® Ready to Take is perfect for those who are looking for constipation relief that fits comfortably into daily life” said Belinda.

MOVICOL® Ready to Take is great for adults and children over 12 years old who are busy, family focused and time-poor.

“The fact that they are premixed sachets rather than powder and are a natural fruit flavoured liquid sachet, means they are a great way for patients to administer MOVICOL® quickly and discreetly” said Belinda.

Ken MacRitchie, General Manager, Norgine Australia and New Zealand said, “The launch of MOVICOL® Ready to Take is important for patients in Australia because it is giving those who suffer with constipation a reliable and convenient option to comfortably overcome their condition. MOVICOL® Ready to Take will add value to healthcare professionals, health systems and more importantly meet patients’ needs.”

The new MOVICOL® Ready to Take formulation offers patients effective constipation treatment and it is now available in pharmacies throughout Australia. MOVICOL® Ready to Take is priced from $11 to $13 for a box of 10 pocket size fruit flavoured sachets.

MOVICOL® has been available for almost 20 years in Australia and this new formulation offers patients on the go, a discrete way to take their laxative.

About MOVICOL® Ready to Take

Each 25 ml sachet contains:
Macrogol 3350 13.125 g
Sodium chloride 350.8 mg
Sodium bicarbonate 178.6 mg
Potassium chloride 50.2 mg

Pre- mixed no preparation required
– no need to dilute with water
Dose: 1 sachet daily. This can be increased to 2 – 3 sachets daily if required
ALWAYS READ THE LABEL. USE ONLY AS DIRECTED. IF SYMPTOMS PERSIST, SEE YOUR HEALTHCARE PROFESSIONAL.

About Norgine

Norgine is a European specialist pharmaceutical company that has been established for over 100 years. In 2015, Norgine’s total revenue was EUR 320 million and the company employs over 1,000 people.

Norgine provides expertise and ‘know how’ in Europe to develop, manufacture and market products that offer real value to healthcare professionals, payers and patients. Norgine’s approach and infrastructure is integrated and focused upon ensuring that Norgine wins partnership opportunities for growth.

Norgine is headquartered in the Netherlands and its global operations are based in Amsterdam and in Harefield, UK. Norgine owns a R&D site in Hengoed, Wales and two manufacturing sites, one in Hengoed, Wales and one in Dreux, France.

For more information, please visit www.norgine.com